Get to Know Dr. James Stevenson
Stevenson came to Cleveland in 2012 after almost two decades at Penn Medicine in Philadelphia, where he played a key role in its acclaimed Mesothelioma and Pleural Program.
His dedication to patients has been lauded, along with his multidisciplinary approach to treatment that includes surgeons, radiation oncologists and pulmonologists.
“For anyone with cancer, it’s going to be the biggest challenge in their lives, where everything becomes very focused in terms of what may lie ahead,” Stevenson said. “There is a lot of passion from families and patients. It’s impossible to not become part of their lives.”
Stevenson also treats peritoneal mesothelioma, a rarer form of the disease that starts in the lining of the abdominal cavity, along with thymic cancer.
His research has focused on advancing treatments for mesothelioma and various malignancies. He was the principal investigator of an earlier clinical trial at the Cleveland Clinic that studied the stem cell inhibitor defactinib and its effectiveness on mesothelioma tumors.
Specialties of Dr. James Stevenson
- Lung cancer
- Pleural mesothelioma
- Clinical research
- Thymic cancer
- Blood diseases
Dr. James Stevenson’s Experience and Medical Education
- Cleveland Clinic
- Penn Medicine
- Thomas Jefferson University Hospital (Fellowship)
- University of Florida College of Medicine (Internship)
- Jefferson Medical College of Thomas Jefferson University (M.D.)
Awards and Certifications
- Board certified in internal medicine
- Board certified in medical oncology
- International Association for the Study of Lung Cancer (Member)
Publications of Dr. James Stevenson
- Khunger, M. et al. (2018, October). Post-treatment changes in hematological parameters predict response to nivolumab monotherapy in non-small cell lung cancer patients. PLOS One.
- Maquilan, G. et al. (2018, April). Analysis of the Relationship Between Response to Chemotherapy and Response to Radiation Therapy in Patients With Non-Small Cell Lung Cancer Receiving Sequential Treatment. American Journal of Clinical Oncology.
- Azzouqa, A.& Stevenson, J.P. (2016, November 25). The evolution of the diminishing role of extrapleural pneumonectomy in the surgical management of malignant pleural mesothelioma. OncoTargets and Therapy.
- Stevenson, J.P., Kalaycio, M. & Bolwell, B. (2016, March). Perspectives in Oncology Drug Pricing. JAMA Oncology.
Thank you for your feedback. Would you like to speak with a Patient Advocate?